Epithin, a target of transforming growth factor-β signaling, mediates epithelial-mesenchymal transition

Biochemical and Biophysical Research Communications

Volumn 395, Issue 4, 2010, Pages 553-559

  Lee, Hyo Seon ^a   Kim, Chungho ^a   Kim, Sang Bum ^a   Kim, Moon Gyo ^b   Park, Dongeun ^a  

^a Seoul National University   (South Korea)

^b Inha University   (South Korea)

Author keywords

Epithelial mesenchymal transition; Epithin; TGF

Indexed keywords

EPITHIN; GENE PRODUCT; SHORT HAIRPIN RNA; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION;

ANIMALS; CELL TRANSDIFFERENTIATION; DOGS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; MESODERM; MICE; NEOPLASMS; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77953124691     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.065     Document Type: Article

References (33)

1. Yang J., and Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14 (2008) 818-829
2. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
3. Xu J., Lamouille S., and Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19 (2009) 156-172
4. Massague J. TGFβ in cancer. Cell 134 (2008) 215-230
5. Netzel-Arnett S., Hooper J.D., Szabo R., Madison E.L., Quigley J.P., Bugge T.H., and Antalis T.M. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 22 (2003) 237-258
6. Oberst M., Anders J., Xie B., Singh B., Ossandon M., Johnson M., Dickson R.B., and Lin C.Y. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am. J. Pathol. 158 (2001) 1301-1311
7. List K., Bugge T.H., and Szabo R. Matriptase: potent proteolysis on the cell surface. Mol. Med. 12 (2006) 1-7
8. List K., Haudenschild C.C., Szabo R., Chen W., Wahl S.M., Swaim W., Engelholm L.H., Behrendt N., and Bugge T.H. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21 (2002) 3765-3779
9. Uhland K. Matriptase and its putative role in cancer. Cell. Mol. Life Sci. 63 (2006) 2968-2978
10. List K., Szabo R., Molinolo A., Sriuranpong V., Redeye V., Murdock T., Burke B., Nielsen B.S., Gutkind J.S., and Bugge T.H. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev. 19 (2005) 1934-1950
11. Ihara S., Miyoshi E., Ko J.H., Murata K., Nakahara S., Honke K., Dickson R.B., Lin C.Y., and Taniguchi N. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β 1-6 GlcNAc branching. J. Biol. Chem. 277 (2002) 16960-16967
12. Jin X., Yagi M., Akiyama N., Hirosaki T., Higashi S., Lin C.Y., Dickson R.B., Kitamura H., and Miyazaki K. Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci. 97 (2006) 1327-1334
13. Suzuki M., Kobayashi H., Kanayama N., Saga Y., Suzuki M., Lin C.Y., Dickson R.B., and Terao T. Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J. Biol. Chem. 279 (2004) 14899-14908
14. Galkin A.V., Mullen L., Fox W.D., Brown J., Duncan D., Moreno O., Madison E.L., and Agus D.B. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts. Prostate 61 (2004) 228-235
15. Cho E.G., Kim M.G., Kim C., Kim S.R., Seong I.S., Chung C., Schwartz R.H., and Park D. N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease. J. Biol. Chem. 276 (2001) 44581-44589
16. Kim C., Cho Y., Kang C.H., Kim M.G., Lee H., Cho E.G., and Park D. Filamin is essential for shedding of the transmembrane serine protease, epithin. EMBO Rep. 6 (2005) 1045-1051
17. Marambaud P., Shioi J., Serban G., Georgakopoulos A., Sarner S., Nagy V., Baki L., Wen P., Efthimiopoulos S., Shao Z., Wisniewski T., and Robakis N.K. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21 (2002) 1948-1956
18. Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., de Strooper B., Hartmann D., and Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. USA 102 (2005) 9182-9187
19. Kim M.G., Chen C., Lyu M.S., Cho E.G., Park D., Kozak C., and Schwartz R.H. Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics 49 (1999) 420-428
20. Suzuki M., Kobayashi H., Tanaka Y., Hirashima Y., Kanayama N., Takei Y., Saga Y., Suzuki M., Itoh H., and Terao T. Bikunin target genes in ovarian cancer cells identified by microarray analysis. J. Biol. Chem. 278 (2003) 14640-14646
21. Yagyu T., Kobayashi H., Wakahara K., Matsuzaki H., Kondo T., Kurita N., Sekino H., Inagaki K., Suzuki M., Kanayama N., and Terao T. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-β and subsequently suppresses TGF-β signalings. FEBS Lett. 576 (2004) 408-416
22. Oberst M.D., Johnson M.D., Dickson R.B., Lin C.Y., Singh B., Stewart M., Williams A., al-Nafussi A., Smyth J.F., Gabra H., and Sellar G.C. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin. Cancer Res. 8 (2002) 1101-1107
23. Vogel L.K., Saebo M., Skjelbred C.F., Abell K., Pedersen E.D., Vogel U., and Kure E.H. The ratio of matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer 6 (2006) 176
24. Carney T.J., von der Hardt S., Sonntag C., Amsterdam A., Topczewski J., Hopkins N., and Hammerschmidt M. Inactivation of serine protease matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis. Development 134 (2007) 3461-3471
25. Szabo R., Molinolo A., List K., and Bugge T.H. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 26 (2007) 1546-1556
26. Cheng H., Fukushima T., Takahashi N., Tanaka H., and Kataoka H. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res. 69 (2009) 1828-1835
27. Santibanez J.F. JNK mediates TGF-β1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett. 580 (2006) 5385-5391
28. Grotegut S., von Schweinitz D., Christofori G., and Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 25 (2006) 3534-3545
29. Camp E.R., Yang A., Gray M.J., Fan F., Hamilton S.R., Evans D.B., Hooper A.T., Pereira D.S., Hicklin D.J., and Ellis L.M. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. Cancer 109 (2007) 1030-1039
30. Lochter A., Galosy S., Muschler J., Freedman N., Werb Z., and Bissell M.J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139 (1997) 1861-1872
31. Hulboy D.L., Matrisian L.M., and Crawford H.C. Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors. Mol. Cell. Biol. 21 (2001) 5478-5487
32. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W., Pinkel D., Bissell M.J., and Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98 (1999) 137-146
33. Jenkins G. The role of proteases in transforming growth factor-β activation. Int. J. Biochem. Cell Biol. 40 (2008) 1068-1078